Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Anabel Costa-Ferreira

Editorial Intern

Anabel is an Editorial and Data Journalism Intern, working primarily within the In Vivo team.

Before joining Norstella, she recently completed a BA English degree at the University of Exeter. Anabel has also spent the past year as Editor-in-Chief of her university’s student paper Exeposé, managing an editorial team to produce a 32-page paper on a fortnightly basis.

During her internship, she is eager to expand her journalistic knowledge, write articles and work on data projects – all as she looks forward to entering the world of biopharma.

Latest From Anabel Costa-Ferreira

Beacon Eye Gene Therapy Efforts Buoyed By Cash Boost

In a major boost for the UK biotech sector, an impressive sum has been raised by Beacon Therapeutics to support its R&D activities in ophthalmic gene therapies.

Ophthalmic Financing

Ashibio Takes Shelved Gilead Drug In New Direction

On the back of a “truly one in a million” case, Ashibio has revived research into Gilead's discontinued asset andecaliximab after it showed promise in the ultra-rare musculoskeletal condition FOP.

Rare Diseases Financing
See All